|
|
|
908 Devices inc (NASDAQ: MASS) |
|
|
|
| |
908 Devices inc Outlook |
On January 15 2025 the 908 Devices inc provided following guidance
nn908 Devices Inc. Provides Preliminary Financial Results for Q4 and Full Year 2024nn
nBoston – January 15, 2025n – 908 Devices Inc. (NASDAQ: MASS), a leader in the development of specialized handheld and desktop devices for chemical analysis, has released its preliminary unaudited financial results for the fourth quarter and full year ending December 31, 2024.
The company anticipates that its revenue for the fourth quarter of 2024 will reach approximately $17.2 million. This represents a notable growth of around 20% compared to the $14.4 million recorded in the same period of 2023. This upward trajectory in revenue highlights the company’s strong performance and its increasing market presence.
Additionally, the growth in the fourth quarter revenue is further bolstered by a significant increase in sales of handheld devices, contributing to the company's overall financial health. These results not only reflect 908 Devices’ commitment to innovation and excellence in chemical analysis technology but also reinforce its position as a market leader in this sector.
As the company continues to advance its technological offerings, it remains focused on delivering exceptional solutions to its clients, paving the way for further growth and expansion in the upcoming years. Detailed financial statements and insights will be provided in the upcoming official financial report.,
|
On November 12 2024 the 908 Devices inc provided following guidance
908 Devices Inc. Issues Financial Update for Third Quarter 2024 and Revises 2024 Revenue Projections
BOSTON, 908 Devices Inc. (Nasdaq: MASS), an innovator in the development of specialized handheld and desktop devices for chemical analysis, has made an announcement regarding its financial performance for the quarter that ended on September 30, 2024. Despite a year-over-year increase in revenue attributed to new product acquisitions, the company acknowledged that its third-quarter performance did not align with internal expectations.
The company cited several factors influencing the shortfall: The delay in the federal budget for fiscal year 2024 has resulted in challenges that hindered progress. Additionally, advancements in international contracts faced setbacks, contributing to overall operational weakness. While 908 Devices remains optimistic about the potential of their new products, these ongoing issues have prompted a need to reassess the revenue outlook for the year ahead.
Specific figures detailing revised revenue targets for 2024 were not included in the latest report, leaving investors and stakeholders seeking further clarity. As 908 Devices navigates these complexities, the company is focused on addressing the challenges to ensure future growth and stability.,
|
On April 30 2024 the 908 Devices inc provided following guidance
908 Devices Inc. (Nasdaq: MASS) had a strong start to 2024, reporting a topline revenue of $10 million for the first quarter. The company continues to see strong demand for their handheld and desktop devices designed for chemical and biochemical analysis. As applications for chemical detection and identification at the point of need gain traction both in the US and internationally, 908 Devices Inc. is well-positioned for continued growth.
The company is optimistic about their revenue outlook for the remainder of 2024 based on the current market trends and demand for their innovative products. With a focus on providing purpose-built devices for a variety of industries, 908 Devices Inc. is confident in their ability to meet the needs of their customers and drive further success in the coming months.
Overall, 908 Devices Inc. is pleased with their performance in the first quarter of 2024 and looks forward to building on this momentum to achieve their financial goals for the year. Investors can expect to see continued growth and success from the company as they capitalize on opportunities in the market for chemical and biochemical analysis solutions.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
